MGS Mfg. Group
MGS Mfg. Group is a privately held healthcare CDMO providing vertically integrated contract development and manufacturing services—including design, tooling, automation, and precision plastic injection molding—to pharmaceutical, diagnostic, and medical technology companies across North America and Europe.
- Company typePrivate
- Founded1982
- HeadquartersGermantown, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What MGS Mfg. Group does
MGS Mfg. Group, Inc. is a privately held healthcare Contract Development and Manufacturing Organization (CDMO) headquartered in Germantown, Wisconsin. Founded in 1982, the company serves pharmaceutical, diagnostic, and medical technology innovators by manufacturing precision plastic components and devices such as drug delivery systems (auto-injectors, pen injectors, wearable injectors, prefilled syringes, nasal spray inhalers), in vitro diagnostic consumables (pipettes, cartridges, cassettes, cuvettes), and high-value MedTech disposables (ophthalmic, cardiovascular, urological, and vascular). Its end customers are global enterprise healthcare companies, and MGS positions itself as a single-source supplier capable of taking products from concept through validated production.
The company operates a vertically integrated service stack spanning design and development (scoping, simulation, regulatory affairs, usability engineering), tooling (multi-cavity molds, Fast-Track Tooling, Hybrid Tooling, ESI/DFM), custom automation (EOAT, indexing, continuous-motion systems compliant with Industry 4.0, Euromap 77/83), and high-volume precision injection molding. Production infrastructure includes more than 350 injection molding machines (28–800 ton capacity) and over 250,000 square feet of Class 7 and Class 8 cleanroom space distributed across facilities in the United States (Germantown, Richfield), Mexico (Juárez), Costa Rica (Cartago), Ireland (Leixlip), Sweden (Anderstorp), Germany (Dortmund), Belgium (Beringen), Denmark (Roskilde, Horsholm, Lynge), and Slovakia. Differentiated technology assets include the patent-pending A.i.r. Platform auto-injector system (fill volumes 0.3–2.25 mL), proprietary multi-shot molding (2/3/4-shot) technology, and modular tooling programs inherited from acquired entities such as Formteknik.
MGS generates revenue through contract development and manufacturing engagements, with revenue streams classified as recurring/project-based contract manufacturing and professional services for design and development work. Pricing is not publicly disclosed and is negotiated on a project-by-project basis. The company sells exclusively through direct enterprise sales and global account management rather than third-party distribution. As of early 2026, following the acquisition of Knudsen Plast A/S, MGS employs approximately 1,600 team members across 13 global facilities. Growth has been driven primarily by an aggressive acquisition strategy—three Denmark-based deals completed between June 2023 and February 2026—and by organic investment in new facilities, including the 120,000-square-foot Innovation Center under construction at its Germantown campus and the 160,000-square-foot Cartago, Costa Rica facility opened in January 2025.
MGS Mfg. Group firmographics
Firmographics- Name
- MGS Mfg. Group
- Legal name
- MGS Mfg. Group, Inc.
- Website
- https://mgsmfg.com
- Company type
- Private
- Founded year
- 1982
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- MGS Mfg. Group is a privately held healthcare CDMO providing vertically integrated contract development and manufacturing services—including design, tooling, automation, and precision plastic injection molding—to pharmaceutical, diagnostic, and medical technology companies across North America and Europe.
- Ownership category
- akta.pro rank
MGS Mfg. Group industry classification
Industry- Product category
- Healthcare Contract Manufacturing
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820)
- akta.pro primary industry
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
- akta.pro secondary industries
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)
Keywords
Where MGS Mfg. Group is headquartered
LocationHeadquarters
- HQ city
- Germantown
- HQ country
- United States
- HQ region
- North America
Offices13 records
Markets served
MGS Mfg. Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Contract Manufacturing Services: MGS generates revenue primarily through contract development and manufacturing services for pharmaceutical, diagnostic, and medical technology companies. This includes injection molding, tooling, automation, and assembly services provided under long-term contractual relationships. Revenue is typically project-based or volume-based manufacturing contracts.
- Design and Development Services: Early-stage product design and development services including scoping, project management, mechanical engineering, test & verification, quality management, user experience design, sustainability engineering, usability engineering, simulation & modeling, design control, and regulatory affairs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
MGS Mfg. Group product offering
Product offeringCore offering
MGS Mfg. Group is a healthcare Contract Development and Manufacturing Organization (CDMO) that provides vertically integrated end-to-end solutions for pharmaceutical, diagnostic, and medical technology companies. Core offerings include product design and development, precision tooling (including Fast-Track and Hybrid Tooling programs), high-precision plastic injection molding in Class 7 and 8 cleanrooms, custom automation systems, and test and validation services. The company also offers the A.i.r. Platform, a patent-pending customizable auto-injector system for drug delivery applications.
Product overview
MGS Mfg. Group is a healthcare Contract Development and Manufacturing Organization (CDMO) offering vertically integrated end-to-end solutions from product design and development through manufacturing and automation. The company's product portfolio includes the A.i.r. Platform (a customizable auto-injector system), Fast-Track Tooling, Hybrid Tooling, and ESI/DFM services. Core services span design and development, precision tooling (with over 200 toolmakers globally), manufacturing (350+ injection molding machines, 250,000+ sq. ft. of Class 7/8 cleanrooms), custom automation solutions, and testing and validation services. The company operates 14 global facilities across North America and Europe, serving pharmaceutical, diagnostic, and MedTech markets.
Differentiator
Problem solved
Functional benefit
Brands
- A.i.r. Platform™: A patent-pending customizable auto-injector system designed to support pharmaceutical innovators, healthcare providers, and diverse patient groups with fill volumes ranging from 0.3 to 2.25 mL. Includes patient-friendly features such as audible feedback and aims to reduce development costs and accelerate time to market for drug-device combinations.
Quantifiable outcome
- Reduced development timelines through Fast-Track Tooling program
- +1 more outcomes
Companies that use MGS Mfg. Group
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
MGS Mfg. Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
MGS Mfg. Group partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Knudsen Plast A/ScoreDenmark-based injection moulder with over 40 years of healthcare manufacturing experience, including nearly 100 injection molding machines and Class 7 and Class 8 cleanrooms. Operations in Denmark and Slovakia. This was MGS' third acquisition in Denmark within 16 months.
- Winther Mould TechnologycoreDanish healthcare tooling manufacturer acquired to enhance capabilities in high-precision plastic solutions for medical applications. Expands tooling and moldmaking capacity.
- MSI GeneralminorNashotah, Wisconsin-based construction partner for the new 120,000-square-foot Innovation Center at MGS' Germantown campus.
- Technolution A/ScoreDanish consulting and development company specializing in pharmaceutical and medtech industries. Acquisition enhances MGS capabilities in product development, regulatory compliance, and project management to accelerate time-to-market.
- FormteknikcoreFormteknik was previously acquired by MGS and contributed the Fast-Track Tooling program concept that has now been expanded to the North American market. The program leverages standardized and modular tooling designs enabling customers to validate parts before full-scale production commitment.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
MGS Mfg. Group competitors and assessment
Company assessmentDirect peers
- Ypsomed Holding: Swiss developer and manufacturer of injection and infusion systems including auto-injectors and pen injectors for self-medication. Direct competitor to MGS in the auto-injector and pen injector segment serving pharma innovators with proprietary device platforms.
- Phillips-Medisize: Medical device CDMO specializing in design, tooling, and high-volume injection molding for pharma, diagnostics, and MedTech customers. Directly comparable to MGS in offering vertically integrated plastic medical device manufacturing with global footprint and regulated-industry certifications.
- SHL Medical: One of the largest independent developers and manufacturers of auto-injectors, pen injectors, and inhalers serving global pharma customers. Directly competes with MGS in drug-delivery device CDMO services, particularly in the auto-injector segment where MGS's A.i.r. Platform is launching.
- West Pharmaceutical Services: Global manufacturer of primary packaging, drug-delivery devices, and injectable components including elastomer seals and auto-injector platforms. Comparable to MGS as a healthcare device CDMO serving pharma innovators with vertically integrated design, tooling, and manufacturing.
- Gerresheimer: Manufacturer of primary packaging (glass and plastic) and drug delivery devices including prefillable syringes and auto-injectors serving pharma and biotech. Comparable to MGS in serving regulated healthcare end markets with high-precision, high-volume plastic component manufacturing.
- Stevanato Group: Provider of drug containment, drug delivery, and diagnostic solutions including prefillable syringes, vials, and inspection systems. Comparable to MGS in precision glass and plastic components for pharma and diagnostics, with similar vertical integration across design, tooling, and manufacturing.
Emerging players
- Westfall Technik: PE-backed healthcare and consumer plastics platform with capabilities in precision injection molding, tooling, and assembly for MedTech customers. Comparable to MGS in precision injection molding and tooling, with similar vertical integration model and growing healthcare focus.
- Micropoint Technologies: Contract manufacturer of precision medical plastic components including microfluidic chips, IVD cartridges, and lab consumables. Comparable to MGS in serving diagnostic and MedTech customers with high-precision injection molding and cleanroom manufacturing.
Broad incumbents
- Becton Dickinson (BD) Medical - Pharmaceutical Systems: Global medical technology company with a Pharmaceutical Systems segment that manufactures prefillable syringes, drug-delivery devices, and self-injection systems. Comparable to MGS in drug-delivery device manufacturing serving major pharma customers, though BD operates at a much larger scale across a broader medical device portfolio.
- Catalent: Large global CDMO providing drug substance, drug product, and biologics development/manufacturing including softgel, oral, sterile injectable, and inhalation. Overlaps with MGS in pharma drug-delivery and combination products but operates at significantly larger scale and across more dosage forms.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
MGS Mfg. Group social profiles
Digital presenceMGS Mfg. Group compliance and trust
Trust signalCompliance6 records
MGS Mfg. Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
MGS Mfg. Group leadership team
Management profileNumber of profiles
Profiles1 record
MGS Mfg. Group subsidiaries and ownership
Company hierarchySubsidiaries4 records
MGS Mfg. Group funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MGS Mfg. Group M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MGS Mfg. Group
What does MGS Mfg. Group do?
MGS Mfg. Group is a healthcare Contract Development and Manufacturing Organization (CDMO) that provides vertically integrated end-to-end solutions for pharmaceutical, diagnostic, and medical technology companies. Core offerings include product design and development, precision tooling (including Fast-Track and Hybrid Tooling programs), high-precision plastic injection molding in Class 7 and 8 cleanrooms, custom automation systems, and test and validation services. The company also offers the A.i.r. Platform, a patent-pending customizable auto-injector system for drug delivery applications.
Is MGS Mfg. Group a public or private company?
MGS Mfg. Group is a private company. It is classified as private equity controlled and is currently operating.
When was MGS Mfg. Group founded?
MGS Mfg. Group was founded in 1982. It employs 1,001 to 5,000 people.
Where is MGS Mfg. Group based?
MGS Mfg. Group is headquartered in Germantown, United States, in the North America region.
How does MGS Mfg. Group make money?
Two revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are design and Development Services.
Who are MGS Mfg. Group's main competitors?
Direct peers on record are Ypsomed Holding, Phillips-Medisize, SHL Medical, West Pharmaceutical Services, Gerresheimer and Stevanato Group. Emerging players are Westfall Technik and Micropoint Technologies. Broad incumbents are Becton Dickinson (BD) Medical - Pharmaceutical Systems and Catalent.
Does MGS Mfg. Group have an API?
No public API is recorded for MGS Mfg. Group.
What industry is MGS Mfg. Group in?
MGS Mfg. Group's product category is Healthcare Contract Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 3391 and its SIC code is 3841.